BHPLF
BHP Group Ltd
$43.78
-3.93%
No data for this timeframe.
Vol
SEC Reports3
Recent Activity
Jun 2, 2026
SEC
BHP Group Ltd filed a Form 6-K disclosing the appointment of Mark Vassella as an independent Non-executive Director effe
6-K — Impact 2/10
May 13, 2026
SEC
BHP appointed Mark Vassella, former CEO of BlueScope Steel, as a Non-executive Director effective June 1, 2026. The appo
6-K — Impact 2/10
Apr 22, 2026
SEC
BHP reported strong operational performance in copper and iron ore for the nine months ended March 31, 2026, with copper
6-K — Impact 7/10
Analyst Ratings
1Strong Buy
7Buy
16Hold
0Sell
0Strong Sell
Latest Reports
NEUTRAL
6-K
2/10
BHP Group Ltd filed a Form 6-K disclosing the appointment of Mark Vassella as an independent Non-executive Director effe
Jun 2, 2026
NEUTRAL
6-K
2/10
BHP appointed Mark Vassella, former CEO of BlueScope Steel, as a Non-executive Director effective June 1, 2026. The appo
May 13, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
3 SEC filing reports analyzed. Sentiment: 1 bullish, 0 bearish, 0 mixed, 2 neutral. Avg impact: 3.7/10.
NEUTRAL
6-K
2/10
BHP Group Ltd filed a Form 6-K disclosing the appointment of Mark Vassella as an independent Non-exe
Jun 2, 2026
NEUTRAL
6-K
2/10
BHP appointed Mark Vassella, former CEO of BlueScope Steel, as a Non-executive Director effective Ju
May 13, 2026
BULLISH
6-K
7/10
BHP reported strong operational performance in copper and iron ore for the nine months ended March 3
Apr 22, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 33% buy across 24 analysts — 1 strong buy, 7 buy, 16 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $57.4B | 12.0% | — |
| Next FY 2027-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $56.9B | -0.8% | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 1 | 7 | 16 | 0 | 0 | 33% | |
| May 1, 2026 | 2 | 7 | 13 | 0 | 1 | 39% | |
| Apr 1, 2026 | 2 | 7 | 13 | 0 | 1 | 39% | |
| Mar 1, 2026 | 2 | 7 | 13 | 0 | 1 | 39% | |
| Feb 1, 2026 | 2 | 7 | 12 | 0 | 1 | 41% | |
| Jan 1, 2026 | 2 | 7 | 12 | 0 | 1 | 41% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.